Synthesis of novel gem-difluorinatedcyclopropane hybrids: Applications for material and medicinal sciences

ACS Symposium Series

Volumn 949, Issue , 2007, Pages 352-362

  Itoh, Toshiyuki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36749031787     PISSN: 00976156     EISSN: None     Source Type: Book Series    
DOI: 10.1021/bk-2007-0949.ch021     Document Type: Conference Paper

References (64)

1. For reviews see: (a) "Cyclopropanes and Related Rings", Chem. Rev. 2003, 103, 931-1648.
2. (b) Tozer, M. J.; Herpin, T. F. Tetrahedron, 1996, 52, 8619-8683.
3. For reviews, see. (a) Welch, J. T. Tetrahedron, 1987, 43, 3123-3197.
4. (b) Resnati, G. Tetrahedron, 1993, 49, 9385-9445.
5. (c) "Enantiocontrolled Synthesis of Fluororganic Compounds: Stereochemical Challenges and Biomedicinal Targets", Ed. Soloshonok, V. A., Wiley, Chichester, UK (1999).
6. (a) Dolbier, Jr. W. R.; Battiste, M. A. Chem. Rev. 2003, 103, 1071-1098.
7. (b) Fedory'nski, M. Chem. Rev. 2003, 103, 1099-1132.
8. Methods for preparing gem-difluorocyclopropanes, see. (a) Sargeant, P. B. J. Org. Chem. 1970, 35, 678-682.
9. (b) Seyferth, D.; Hopper, S. P. J. Org Chem. 1972, 37, 4070-4075.
10. (c) Schlosser, M.; Chau, L-V.; Bojana, S. Helv. Chim. Acta, 1975, 58, 2575-2585.
11. (d) Schlosser, M.; Spahi'c; B.; Chau, L-V. Helv. Chim. Acta, 1975, 58, 2586-2604.
12. (e) Schlosser, M.; Bessard, Y. Tetrahedron, 1990, 46, 5222-5229.
13. (f) Morikawa, T.; Uejima. M.; Kobayashi, Y. Chem. Lett. 1988, 1407-1710.
14. (g) Bessard, Y.; Müller, U.; Schlosser, M. Tetrahedron, 1990, 46, 5213-5221.
15. (h) Schlosser, M.; Bessard, Y. Tetrahedron, 1990, 46, 5222-5229.
16. (i) Tian, F.; Battiste, M. A.; Dolbier, Jr. W. R. Org. Lett. 1999, 7, 193-195.
17. (j) Tian, F.; Kruger, V.; Bautista, O.; Duan, J-X.; Li, A-R.; Dolbier, Jr. W. R.; Chen, Q-Y. Org. Lett. 2000, 2, 563-564.
18. Our examples for preparing optically active gem-difluorocyclopropanes. (a) Itoh, T.; Mitsukura, K.; Furutani, M. Chem. Lett. 1998, 903-904.
19. (b) Mitsukura, K.; Korekiyo, S.; Itoh, T. Tetrahedron Lett. 1999, 40, 5739-5742.
20. (c) Itoh, T.; Mitsukura, K.; Ishida, N.; Uneyama, K. Org. Lett. 2000, 2, 1431-1434.
21. (d) Itoh, T. J. Synth. Org. Chem. Jpn. 2000, 58, 316-326.
22. (e) Itoh, T.; Ishida, N.; Mitsukura, K.; Uneyama, K. J. Fluorine Chem. 2001, 112, 63-69.
23. (f) Itoh, T.; Ishida, N.; Mitsukura, K.; Hayase, S.; Ohashi, K.J. Fluorine Chem. 2004, 125, 775-783.
24. (a) J. R. Pfister, F. Makra, A. V. Muehldorf, H. Wu, J. T. Nelson, P. Cheung, N. A. Bruno, S. M. Casey, N. Zutshi and D. L. Slate, Biorganic Med. Chem. Lett. 1995, 5, 2473-2476.
25. (b) Barnett, Charles J.; Huff, Bret; Kobierski, Michael E.; Letourneau, Michael; Wilson, Thomas M. J. Org. Chem. 2004, 69, 7653-7660.
26. Boger, D. L.; Jenkins, T. J. J. Am. Chem. Soc. 1996, 118, 8860-8870.
27. Koizumi, N.; Takrgawa, S.; Mieda, M.; Shibata, K. Chem. Pharm. Bull. 1996, 44, 2162-2164.
28. Taguchi, T.; Shibuya, A.; Sasaki, H.; Endo, J-i.; Morikawa, T. ; Shiro, M. Tetrahedron: Asymmetry, 1994, 5, 1423-1426.
29. (a) Taguchi, T.; Shibuya, A.; Sasaki, H.; Endo, J-i.; Morikawa, T. ; Shiro, M. Tetrahedron: Asymmetry, 1994, 5, 1423-1426.
30. (b) Taguchi, T.; Kurishita, M.; Shibuya, A.; Aso, K. Tetrahedron, 1997, 53, 9497-9508.
31. (a) Shibuya, A.; Kurishita, M.; Ago, C.; Taguchi, T. Tetrahedron, 1996, 52, 271-278.
32. (b) Taguchi, T.; Kurishita, M.; Shibuya, A.; Aso, K. Tetrahedron, 1997, 53, 9497-9508.
33. (c) Shibuya, A.; Sato, A.; Taguchi, T. Bioorganic & Medicinal Chem. Lett. 1998, 8, 1979-1984.
34. (d) Shibuya, A.; Okada, M.; Nakamura, Y.; Kibashi, M.; Horikawa, H.; Taguchi, T. Tetrahedron, 1999, 55, 10325-10340.
35. Pechacek, J. T.; Bargar, T. M.; Sabol, M. R. Bioorg. Med. Chem. Lett. 1997, 7, 2665-2668.
36. (a) Csuk, R.; Eversmann, L. Tetrahedron, 1998, 54, 6445-6459.
37. (b) Csuk, R.; Thiede, G. Tetrahedron, 1999, 55, 739-750.
38. (c) Csuk, R.; Eversmann, L. Zeitschrift fuer Naturforschung, B: Chemical Sciences, 2003, 58, 997-1004.
39. (d) Csuk, R.; Thiede, G. Zeitschrift fuer Naturforschung, B: Chemical Sciences, 2003, 58, 853-860.
40. (e) Csuk, R.; Eversmann, L. Zeitschrift fuer Naturforschung, B: Chemical Sciences, 2003, 58, 1176-1186.
41. (a) Kirihara, M.; Takuwa, T.; Kawasaki, M.; Kakuda, H.; Hirokami, S-i.; Takahata, H. Chem. Lett. 1999, 405-406.
42. (b) Kirihara, M.; Kawasaki, M.; Takuwa, T.; Kakuda, H.; Wakikawa, T.; Takeuchi, Y.; Kirk, K. L. Tetrahedron. Asymm. 2003, 14, 1753-1761.
43. Roe, R. M.; Kallapur, V.; Linderman, R. J.; Viviani, F. Pesticide Biochemistry and Physiology, 2005, 83(2-3), 140-154.
44. (a) Ren, Y.; Lodge, T. P.; Hillmyer, M. A. J. Am. Chem. Soc. 1998, 120, 6830-6831.
45. (b) Ren, Y.; Lodge, T. P.; Hillmyer, M. A. Macromolecules, 2000, 33, 866-876.
46. (c) Reisinger, J. J.; Hillmyer, M. A. Prog. Polym. Sci. 2002, 27, 971-1005.
47. (d) Hillmyer, M. A.; Schmuhl, N. W.; Lodge, T. P. Macromol. Symp. 2004, 215, 51-56.
48. Miyazawa, K.; Yufit, D. S.; Howard, J. A. K.; de Meijere, A. Eur. J. Org. Chem. 2000, 4109-4117.
49. Itoh, T.; Ishida, N.; Ohashi, M.; Asep, R.; Nohira, H. Chem. Lett. 2003, 32, 494-495.
50. Itoh, T. ACS Symposium Series #911, Ed, V. A. Soloshonok, Oxford University Press/ American Chemical Society: Washington DC, Chapter 25, pp.430-439 (2005).
51. For reviews, see: (a) Ros, T. D.; Spalluto G.; Boutorine, A. S.; Bensasson, R. V.; Prato, M. Current Pharmaceutical Design, 2001, 7, 1781-1821.
52. (b) Armitage, B. Chem. Rev. 1998, 98, 1171-1200.
53. (a) Ly, D.; Kan, Y.; Armitage, B.; Schuster, G. B. J. Am. Chem. Soc. 1996, 118, 8747-8748.
54. (b) Gasper, S. M.; Armitage, B.; Shi, X.; Hu, G. G.; Yu, C.; Schuster, G. B.; Williams, L. D. J. Am. Chem. Soc. 1998, 120, 12402-12409.
55. Kumar, C. V.; Punzalan, E. H. A.; Tan, W. B. Tetrahedron, 2000, 56, 7027-7040.
56. (a) Toshima, K.; Takano, R.; Maeda, Y.; Suzuki, M.; Asai, A.; Matsumura, S. Angew. Chem. Int. Ed 1999, 38, 3733-3735.
57. (b) Toshima, K.; Maeda, Y.; Ouchi, H.; Asai, A.; Matsumura, S. Bioorganic & Medicinal Chem. Lett. 2000, 10, 2163-2165.
58. (c) Toshima, K.; Takai, S.; Maeda, Y.; Takano, R.; Matsumura, S. Angew. Chem. Int. Ed 2000, 39, 3656-3658.
59. (d) Toshima, K.; Takano, R.; Ozawa, T.; Matsumura, S. Chem. Commun. 2002, 212-213.
60. Tian, F.; Bartberger, M. D.; Dolbier, W. R. Jr. J. Org. Chem. 1999, 64, 540-545.
61. (a) Boger, D. L.; Patane, M. A.; Zhou, J. J. Am. Chem. Soc. 1994, 116, 8544.
62. (b) Helissey, P.; Bailly, C.; Vishwakarma, J. N.; Auclair, C.; Waring, M. J.; Giorgi-Renault, S. Anticancer Drug Des. 1996, 11, 527.
63. (c) Amishiro, N.; Nagamura, S.; Murakata, C.; Okamoto, A.; Kobayashi, E.; Asada, M.; Gomi, K.; Tamaoki, T.; Okabe, M.; Yamaguchi, N.; Yamaguchi, K.; Saito, H. Bioorganic & Medicinal Chem. 2000, 8, 381-391.
64. Ninomiya, K.; Tanimoto, K.; Ishida, N.; Horiii, D.; Sisido, M.; Itoh, T. J. Fluorine Chem. 2006, 127, in press.